[转载]美国NPE专利经营模式受到挑战?
(2011-10-20 22:00:47)
标签:
转载 |
原文地址:美国NPE专利经营模式受到挑战?作者:智财
调查显示2010年美国NPE的专利诉讼成功率大幅下降
最近出版的2010年版美国专利诉讼调查显示,非执业实体(Non-practising entities,NPE)的专利诉讼胜诉率要低于执业实体(practising entities ),前者为21%,后者为38%,这是自2007年来首次出现实业公司在诉讼上比NPE更成功的情形,2009年NPE的胜诉率还曾高达47%。这似乎意味着美国的Patent Troll/NPE的专利经营模式,在美国专利法改革的浪潮中受到挑战。当然,具体的情况还有待观察。
2010美国专利诉讼调查请见http://www.yesipo.com/read.php?tid=2347。
New survey reports a sharp drop in NPE litigation success rates in the US during 2010
Non-practising entities have a lower success rate in US patent litigation than practising entities, according to PWC, which today published the 2011 edition of its annual US patent litigation survey . According to the firm, NPEs were successful 21% of the time in 2010, while operating companies prevailed 38% of the time. The discrepancy is largely accounted for by NPE’s relative lack of success in summary actions; when it comes to trials they prevailed around two-thirds of the time, as did operating companies.
Last
The number of patent cases filed in 2010 recovered slightly from 2009, but at 2,892 the overall amount remains lower than the figure for 2008 (2,937) and the all-time high of 3,075 reached in 2004. The survey does not look at the number of defendants per case. Other highlights of the survey identified by PWC include:
•
• The disparity between jury and bench awards continues to widen and is likely the contributing factor in the significant increase in use of juries since 1995.
•
• Technology associated with the consumer products industry led the way in the percentage of identified decisions from 1995 through 2010. However, median damages awarded in this industry were relatively low in comparison to the other top ten most active industries, particularly telecommunications, medical devices, computer hardware/electronics, and biotechnology/pharma.
•
• Certain federal district courts (particularly Virginia Eastern, Delaware, and Texas Eastern) continue to be more favorable to patent holders, with shorter time-to-trial, higher success rates, and higher median damages awards.
•
后一篇:治色盲,然后立公信